What did @amyinhalf actually say?
She got it mostly right. After losing 160 pounds with semaglutide (Ozempic), @amyinhalf showed her loose skin on camera and pushed back on the framing that the drug itself caused it. "There's nothing in a GLP-1 medication that caused my saggy skin," she said. "Lose a lot of weight, you'll have loose skin." That's a reasonable and largely accurate correction to a common misconception circulating on weight loss TikTok.
The video is responding to a commenter who apparently blamed Ozempic specifically for loose skin. Amy's counter-argument is that skin laxity after significant weight loss is a mechanical consequence of losing fat volume, not a pharmacological side effect of the drug. That distinction matters, and it's one most people, including some clinicians, blur.
Does the science back this up?
Mostly yes, with one important nuance she didn't mention. The basic mechanics are well established: rapid or large-magnitude weight loss reduces the fat that supports dermal tissue, and skin that has been stretched over years doesn't always retract. Speed of loss can make this worse.
A 2021 review by Koliaki et al. in Current Obesity Reports confirmed that skin laxity after bariatric-level weight loss is driven by fat volume reduction and collagen degradation over time, not by any specific drug mechanism. Semaglutide trials, including the STEP 1 trial (Wilding et al., 2021, NEJM), showed average weight loss of around 15% body weight over 68 weeks. That's meaningful but slower than surgical weight loss, which actually tends to produce more dramatic loose skin.
The nuance she skipped: GLP-1 agonists may accelerate muscle loss alongside fat loss if protein intake and resistance training aren't managed. Muscle bulk helps fill skin. That's not the same as the drug "causing" loose skin, but it's a real factor worth naming.
What did they get wrong (or right)?
She got the core claim right. Loose skin after significant weight loss is about physics, not pharmacology. Credit where it's due.
What she underplayed is the rate-of-loss question. GLP-1 medications can drive weight loss faster than many people's bodies have experienced before, and faster loss is associated with more pronounced skin laxity. A 2022 analysis by Pouwels et al. in Obesity Surgery found that rate of weight loss was an independent predictor of excess skin requiring panniculectomy in post-bariatric patients. That doesn't mean Ozempic is uniquely guilty, but it's not entirely irrelevant either.
She also didn't mention that age, genetics, sun exposure history, and prior pregnancy all affect how much skin rebounds. Some people lose 50 pounds and have significant laxity. Others lose 150 and bounce back reasonably well. The drug gets blamed for outcomes that are actually highly individual.
- Loose skin is driven by fat volume loss, not GLP-1 drug chemistry. Accurate.
- Any large weight loss can cause this. Accurate.
- Rate of loss and muscle preservation are relevant factors she didn't address. Omission, not inaccuracy.
What should you actually know?
If you're on a GLP-1 medication and worried about loose skin, the drug isn't the villain, but your habits during weight loss matter more than most people realize.
Resistance training and adequate protein intake during active weight loss help preserve lean muscle mass, which physically supports skin from underneath. A 2023 study by Wharton et al. in Obesity noted that GLP-1 users who incorporated structured resistance training showed better lean mass retention than those who relied on the drug alone. Skin doesn't care what medication you're on. It responds to the structural changes underneath it.
For people who lose 100 pounds or more, loose skin is often a near-inevitable outcome regardless of how the weight was lost. Surgical correction (panniculectomy or body contouring) is the only proven intervention for significant excess skin. No cream, collagen supplement, or topical product has strong clinical evidence for reversing post-weight-loss skin laxity at scale.
@amyinhalf's framing, "I'll take this all day because my health has gotten a whole lot better," reflects a reasonable trade-off calculus that the clinical literature supports. Obesity-related comorbidities carry far greater health risks than the cosmetic consequences of losing weight.